Contact

All Stories

  1. Profiling cognition and brain metabolism in amyotrophic lateral sclerosis and frontotemporal dementia

    Article • Brain, October 2025, Oxford University Press (OUP)

    Prof. Cristoforo Comi

  2. “Recommendations for clinical study protocols for immune and inflammatory profiling in Parkinson’s disease”

    Article • npj Parkinson s Disease, October 2025, Springer Science + Business Media

    Prof. Cristoforo Comi

  3. The Association of Axonal Damage Biomarkers and Osteopontin at Diagnosis Could Be Useful in Newly Diagnosed MS Patients

    Article • Neurology International, July 2025, MDPI AG

    Prof. Cristoforo Comi

  4. The importance of early biomarkers in the identification of neurodegenerative disorders

    Article • F1000Research, July 2025, Faculty of 1000, Ltd.

    Prof. Cristoforo Comi

  5. Effects of GBA1 Variants in Patients With Parkinson's Disease and Levodopa–Carbidopa Intestinal Gel: A Nation‐Wide, Multicenter, Longitudinal, “Real‐World” Study. The EPIC Study

    Article • European Journal of Neurology, July 2025, Wiley

    Prof. Cristoforo Comi, Alessio Di Fonzo

  6. Neutrophil-to-Lymphocyte Ratio in the Alzheimer’s Disease Continuum

    Article • International Journal of Molecular Sciences, May 2025, MDPI AG

    Prof. Cristoforo Comi

  7. Extracellular Vesicles as a Potential Biomarker of Pulmonary Arterial Hypertension in Systemic Sclerosis

    Article • Pharmaceuticals, February 2025, MDPI AG

    Prof. Cristoforo Comi

  8. IMMUnity Unveiled: A Translational NETwork for tackling PARKinson's Disease – IMMUPARKNET

    Article • Open Research Europe, January 2025, Faculty of 1000, Ltd.

    Prof. Cristoforo Comi

  9. Biomarkers of Intrathecal Synthesis May Be Associated with Cognitive Impairment at MS Diagnosis

    Article • International Journal of Molecular Sciences, January 2025, MDPI AG

    Prof. Cristoforo Comi

  10. Effect of alemtuzumab on fatigue, quality of life, and patient/caregiver-reported outcomes in relapsing-remitting multiple sclerosis—A real-world evidence study

    Article • Multiple Sclerosis and Related Disorders, January 2025, Elsevier

    Prof. Cristoforo Comi

  11. (Dys)regulation of the Immune System in Parkinson’s Disease: Methodologies, Techniques, and Key Findings from Human Studies

    Article • Aging and Disease, January 2025, Aging and Disease

    Prof. Cristoforo Comi

  12. Kappa index for multiple sclerosis diagnosis: an accurate biomarker of intrathecal synthesis

    Article • Deutsche Zeitschrift für Nervenheilkunde, December 2024, Springer Science + Business Media

    Prof. Cristoforo Comi

  13. A Novel GBF1 Variant in a Charcot-Marie-Tooth Type 2: Insights from Familial Analysis

    Article • Genes, November 2024, MDPI AG

    Prof. Cristoforo Comi

  14. CD4+ T-cell transcription factors predict phenoconversion in idiopathic rapid eye movement sleep behavior disorder

    Article • Future Science OA, November 2024, Taylor & Francis

    Prof. Cristoforo Comi

  15. Family History in Parkinson's Disease: A National Cross‐Sectional Study

    Article • Movement Disorders Clinical Practice, September 2024, Wiley

    Prof. Cristoforo Comi

  16. Coupling motor evoked potentials and brain [18F]FDG-PET in Amyotrophic Lateral Sclerosis: preliminary findings on disease severity

    Article • Neurobiology of Disease, September 2024, Elsevier

    Prof. Cristoforo Comi

  17. Deterioration of people with Parkinson’s symptoms during COVID-19 lockdown: results of a web-based survey in Northwestern Italy

    Article • Aging & Mental Health, August 2024, Taylor & Francis

    Prof. Cristoforo Comi

  18. From Mild Cognitive Impairment to Dementia: The Impact of Comorbid Conditions on Disease Conversion

    Article • Biomedicines, July 2024, MDPI AG

    Prof. Cristoforo Comi

  19. Polymorphisms in the Dopaminergic Receptor D3 Gene Correlate with Disease Progression Rate in Relapsing–Remitting Multiple Sclerosis Patients

    Article • Genes, June 2024, MDPI AG

    Prof. Cristoforo Comi

  20. The Role of Diet in Multiple Sclerosis Onset: A Prospective Study Using UK Biobank

    Article • Nutrients, June 2024, MDPI AG

    Prof. Cristoforo Comi

  21. Novel Therapeutic Strategies in Alzheimer’s Disease: Pitfalls and Challenges of Anti-Amyloid Therapies and Beyond

    Article • Journal of Clinical Medicine, May 2024, MDPI AG

    Prof. Cristoforo Comi

  22. Lifestyle Modulators of Neuroplasticity in Parkinson’s Disease: Evidence in Human Neuroimaging Studies

    Article • CNS & Neurological Disorders - Drug Targets, May 2024, Bentham Science Publishers

    Prof. Cristoforo Comi

  23. New Insights into the Relationship between Nutrition and Neuroinflammation in Alzheimer's Disease: Preventive and Therapeutic Perspectives

    Article • CNS & Neurological Disorders - Drug Targets, May 2024, Bentham Science Publishers

    Prof. Cristoforo Comi

  24. Gas6/TAM system as potential biomarker for multiple sclerosis prognosis

    Article • Frontiers in Immunology, April 2024, Frontiers

    Prof. Cristoforo Comi

  25. Experimental Models to Study Immune Dysfunction in the Pathogenesis of Parkinson’s Disease

    Article • International Journal of Molecular Sciences, April 2024, MDPI AG

    Prof. Cristoforo Comi, Dr Jasna Saponjic

  26. Serum and cerebrospinal fluid neurofilament light chains measured by SIMOA™, Ella™, and Lumipulse™ in multiple sclerosis naïve patients.

    Article • Multiple Sclerosis and Related Disorders, February 2024, Elsevier

    Prof. Cristoforo Comi

  27. Menstrual‐Related Fluctuations in a Juvenile‐Onset Parkinson's Disease Patient Treated with STN‐DBS: Correlation with Local Field Potentials

    Article • Movement Disorders Clinical Practice, December 2023, Wiley

    Prof. Cristoforo Comi

  28. Variability in Clinical Phenotype in TARDBP Mutations: Amyotrophic Lateral Sclerosis Case Description and Literature Review

    Article • Genes, November 2023, MDPI AG

    Prof. Cristoforo Comi

  29. Circulating Extracellular Vesicles in Subarachnoid Hemorrhage Patients: Characterization and Cellular Effects

    Article • International Journal of Molecular Sciences, October 2023, MDPI AG

    Prof. Cristoforo Comi

  30. Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY)

    Article • Neurotherapeutics, October 2023, Elsevier

    Prof. Cristoforo Comi

  31. Real-world use of Safinamide in motor fluctuating Parkinson’s disease patients in Italy

    Article • Neurological Sciences, September 2023, Springer Science + Business Media

    Prof. Cristoforo Comi

  32. Studies to Assess the Utility of Serum Neurofilament Light Chain as a Biomarker in Chemotherapy-Induced Peripheral Neuropathy

    Article • Cancers, August 2023, MDPI AG

    Prof. Cristoforo Comi

  33. Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants

    Article • Genes, August 2023, MDPI AG

    Prof. Cristoforo Comi

  34. Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study

    Article • Deutsche Zeitschrift für Nervenheilkunde, July 2023, Springer Science + Business Media

    Prof. Cristoforo Comi

  35. Investigating the Prognostic Role of Peripheral Inflammatory Markers in Mild Cognitive Impairment

    Article • Journal of Clinical Medicine, June 2023, MDPI AG

    Prof. Cristoforo Comi

  36. Plasma Pattern of Extracellular Vesicles Isolated from Hepatitis C Virus Patients and Their Effects on Human Vascular Endothelial Cells

    Article • International Journal of Molecular Sciences, June 2023, MDPI AG

    Prof. Cristoforo Comi

  37. A novel GRN mutation in an Italian patient with non-fluent variant of primary progressive aphasia at onset: a longitudinal case report

    Article • Frontiers in Neuroscience, June 2023, Frontiers

    Prof. Cristoforo Comi

  38. Meet the Co-Editor

    Article • CNS & Neurological Disorders - Drug Targets, June 2023, Bentham Science Publishers

    Prof. Cristoforo Comi

  39. Isolated Myelopathy in Occult Breast Carcinoma with Negative Paraneoplastic Antibodies: A Case Report of a Rare Condition

    Article • Sclerosis, May 2023, MDPI AG

    Prof. Cristoforo Comi

  40. The PROB-PD trial: a pilot, randomised, placebo-controlled study protocol to evaluate the feasibility and potential efficacy of probiotics in modulating peripheral immunity in subjects with Parkinson’s disease

    Article • Pilot and Feasibility Studies, May 2023, Springer Science + Business Media

    Prof. Cristoforo Comi

  41. Prognostic Role of Visual Evoked Potentials in Non-Neuritic Eyes at Multiple Sclerosis Diagnosis

    Article • Journal of Clinical Medicine, March 2023, MDPI AG

    Prof. Cristoforo Comi

  42. Relationship between [123I]FP-CIT SPECT data and peripheral CD4 + T cell profile in newly-diagnosed drug-naïve Parkinson’s disease patients

    Article • Deutsche Zeitschrift für Nervenheilkunde, February 2023, Springer Science + Business Media

    Prof. Cristoforo Comi

  43. Levodopa Equivalent Dose of Safinamide: A Multicenter, Longitudinal, Case–Control Study

    Article • Movement Disorders Clinical Practice, February 2023, Wiley

    Alessio Di Fonzo, Prof. Cristoforo Comi

  44. Early Predictors of Disability and Cognition in Multiple Sclerosis Patients: A Long-Term Retrospective Analysis

    Article • Journal of Clinical Medicine, January 2023, MDPI AG

    Prof. Cristoforo Comi

  45. The Need for Biomarkers in the ALS–FTD Spectrum: A Clinical Point of View on the Role of Proteomics

    Article • Proteomes, January 2023, MDPI AG

    Prof. Cristoforo Comi

  46. Neuroimaging in multiple system atrophy

    Article • January 2023, Elsevier

    Prof. Cristoforo Comi

  47. Disease mechanisms as subtypes: Immune dysfunction in Parkinson's disease

    Article • January 2023, Elsevier

    Prof. Cristoforo Comi

  48. Biomarkers in multiple sclerosis

    Article • January 2023, Elsevier

    Prof. Cristoforo Comi

  49. Impact of treatment with dimethyl fumarate on sleep quality in patients with relapsing-remitting multiple sclerosis: A multicentre Italian wearable tracker study

    Article • Multiple Sclerosis Journal - Experimental Translational and Clinical, January 2023, SAGE Publications

    Prof. Cristoforo Comi

  50. COVID-19 Vaccination and Late-Onset Myasthenia Gravis: A New Case Report and Review of the Literature

    Article • International Journal of Environmental Research and Public Health, December 2022, MDPI AG

    Prof. Cristoforo Comi

  51. Visuospatial Deficits are associated with Pisa Syndrome and not Camptocormia in Parkinson's disease

    Article • Movement Disorders Clinical Practice, October 2022, Wiley

    Dr Christian Geroin, Prof. Cristoforo Comi, Carlo Alberto Artusi

  52. T Lymphocytes in Parkinson’s Disease

    Article • Journal of Parkinson’s Disease, September 2022, IOS Press

    Prof. Cristoforo Comi

  53. Lymphocyte Count and Neutrophil-to-Lymphocyte Ratio Are Associated with Mild Cognitive Impairment in Parkinson’s Disease: A Single-Center Longitudinal Study

    Article • Journal of Clinical Medicine, September 2022, MDPI AG

    Prof. Cristoforo Comi

  54. PTPA variants and impaired PP2A activity in early-onset parkinsonism with intellectual disability

    Article • Brain, September 2022, Oxford University Press (OUP)

    Prof. Cristoforo Comi

  55. Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients With Primary Progressive Multiple Sclerosis

    Article • JAMA Neurology, September 2022, American Medical Association (AMA)

    Prof. Cristoforo Comi

  56. Safety of COVID-19 Vaccines: Spotlight on Neurological Complications

    Article • Life, August 2022, MDPI AG

    Prof. Cristoforo Comi

  57. A very early onset of juvenile parkinsonism

    Article • Deutsche Zeitschrift für Nervenheilkunde, July 2022, Springer Science + Business Media

    Prof. Cristoforo Comi

  58. The Effects of COVID-19-Related Restrictions on Parkinson’s Disease Patients in Italy: Results of a Structured Survey

    Article • Journal of Clinical Medicine, May 2022, MDPI AG

    Prof. Cristoforo Comi

  59. Early Successful Eye Movement Desensitization and Reprocessing (EMDR) Therapy for Verbal Memory Impairment in an Adjustment Disorder: A Case Report in a Newly-Diagnosed Multiple Sclerosis Patient

    Article • Reports — Medical Cases Images and Videos, May 2022, MDPI AG

    Prof. Cristoforo Comi

  60. Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study

    Article • The Lancet Digital Health, May 2022, Elsevier

    Prof. Cristoforo Comi

  61. Striatal dopamine transporter imaging in Parkinson’s disease drug-naïve patients: focus on sexual dysfunction

    Article • Neurological Sciences, April 2022, Springer Science + Business Media

    Prof. Cristoforo Comi

  62. The Role of Tau beyond Alzheimer’s Disease: A Narrative Review

    Article • Biomedicines, March 2022, MDPI AG

    Prof. Cristoforo Comi

  63. Immune Response Modifications in the Genetic Forms of Parkinson’s Disease: What Do We Know?

    Article • International Journal of Molecular Sciences, March 2022, MDPI AG

    Prof. Cristoforo Comi

  64. The Immune System as a Therapeutic Target for Old and New Drugs in Parkinson’s Disease

    Article • CNS & Neurological Disorders - Drug Targets, March 2022, Bentham Science Publishers

    Prof. Cristoforo Comi

  65. Predicting functional impairment trajectories in amyotrophic lateral sclerosis: a probabilistic, multifactorial model of disease progression

    Article • Deutsche Zeitschrift für Nervenheilkunde, March 2022, Springer Science + Business Media

    Prof. Cristoforo Comi

  66. Meet the Editorial Board Member

    Article • Current Pharmaceutical Biotechnology, March 2022, Bentham Science Publishers

    Prof. Cristoforo Comi

  67. Oxidative Stress in Non-Alcoholic Fatty Liver Disease

    Article • Livers, February 2022, MDPI AG

    Prof. Cristoforo Comi

  68. Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

    Article • Nature Genetics, January 2022, Springer Science + Business Media

    Prof. Cristoforo Comi, MD MARIA SOFIA COTELLI

  69. Cerebrospinal fluid biomarkers and cognitive functions at multiple sclerosis diagnosis

    Article • Deutsche Zeitschrift für Nervenheilkunde, January 2022, Springer Science + Business Media

    Prof. Cristoforo Comi

  70. Susac Syndrome: an uncommon cause of impaired vision

    Article • Neurological Sciences, January 2022, Springer Science + Business Media

    Prof. Cristoforo Comi

  71. Did the role of the neurologist in the emergency department change during the COVID-19 pandemic? Evidence from an Italian nationwide survey

    Article • Neurological Sciences, January 2022, Springer Science + Business Media

    Prof. Cristoforo Comi

  72. Contribution of Rare and Low-Frequency Variants to Multiple Sclerosis Susceptibility in the Italian Continental Population

    Article • Frontiers in Genetics, January 2022, Frontiers

    Prof. Cristoforo Comi

  73. Is There any Link between Madelung Disease and Ischemic Stroke? A Case Report

    Article • Neurology India, January 2022, Medknow

    Prof. Cristoforo Comi

  74. Clinical relevance of single-subject brain metabolism patterns in amyotrophic lateral sclerosis mutation carriers

    Article • NeuroImage Clinical, January 2022, Elsevier

    Prof. Cristoforo Comi

  75. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

    Article • Nature Genetics, December 2021, Springer Science + Business Media

    Prof. Cristoforo Comi, MD MARIA SOFIA COTELLI

  76. Why searching for Anti-Contactin-1 antibodies in chronic inflammatory demyelinating polyneuropathy: a case report.

    Article • Neuroimmunology Reports, December 2021, Elsevier

    Prof. Cristoforo Comi

  77. Serum Vitamin D as a Marker of Impaired Information Processing Speed and Early Disability in Multiple Sclerosis Patients

    Article • Brain Sciences, November 2021, MDPI AG

    Prof. Cristoforo Comi

  78. Motor and non-motor symptom improvement after mRNA-1273 vaccine in a Parkinson’s disease patient

    Article • Neurological Sciences, November 2021, Springer Science + Business Media

    Prof. Cristoforo Comi

  79. Guillain–Barrè syndrome following COVID-19 vaccine mRNA-1273: a case report

    Article • Acta Neurologica Belgica, November 2021, Springer Science + Business Media

    Prof. Cristoforo Comi

  80. Increased Prevalence of Neuropsychiatric Disorders during COVID-19 Pandemic in People Needing a Non-Deferrable Neurological Evaluation

    Article • Journal of Clinical Medicine, November 2021, MDPI AG

    Prof. Cristoforo Comi

  81. Cerebrospinal Tau levels as a predictor of early disability in multiple sclerosis

    Article • Multiple Sclerosis and Related Disorders, November 2021, Elsevier

    Prof. Cristoforo Comi

  82. An Investigation of the Role of Common and Rare Variants in a Large Italian Multiplex Family of Multiple Sclerosis Patients

    Article • Genes, October 2021, MDPI AG

    Prof. Cristoforo Comi

  83. CSF Tau protein correlates with cognitive impairment in multiple sclerosis patients at diagnosis

    Article • Journal of the Neurological Sciences, October 2021, Elsevier

    Prof. Cristoforo Comi

  84. Neuromyelitis optica with syringomyelia: A case report and neurosonological follow up

    Article • Journal of the Neurological Sciences, October 2021, Elsevier

    Prof. Cristoforo Comi

  85. A challenging diagnosis of neurodegenerative dementia: Psychiatric onset of frontotemporal lobar degeneration

    Article • Journal of the Neurological Sciences, October 2021, Elsevier

    Prof. Cristoforo Comi

  86. The impact of COVID-19 pandemic on cognition of people with dementia

    Article • Journal of the Neurological Sciences, October 2021, Elsevier

    Prof. Cristoforo Comi

  87. The Impact of SNCA Variations and Its Product Alpha-Synuclein on Non-Motor Features of Parkinson’s Disease

    Article • Life, August 2021, MDPI AG

    Prof. Cristoforo Comi

  88. Risk of Persistent Disability in Patients With Pediatric-Onset Multiple Sclerosis

    Article • JAMA Neurology, June 2021, American Medical Association (AMA)

    Prof. Cristoforo Comi

  89. Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19

    Article • Disease Markers, May 2021, Hindawi Publishing Corporation

    Prof. Cristoforo Comi

  90. The Impact of the COVID-19 Pandemic on the Cognition of People with Dementia

    Article • International Journal of Environmental Research and Public Health, April 2021, MDPI AG

    Prof. Cristoforo Comi

  91. Expression of Transcription Factors in CD4 + T Cells as Potential Biomarkers of Motor Complications in Parkinson’s Disease

    Article • Journal of Parkinson’s Disease, April 2021, IOS Press

    Prof. Cristoforo Comi

  92. Polymorphisms of Dopamine Receptor Genes and Parkinson’s Disease: Clinical Relevance and Future Perspectives

    Article • International Journal of Molecular Sciences, April 2021, MDPI AG

    Prof. Cristoforo Comi

  93. Telehealth in Neurodegenerative Diseases: Opportunities and Challenges for Patients and Physicians

    Article • Brain Sciences, February 2021, MDPI AG

    Prof. Cristoforo Comi

  94. A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES Trial

    Article • Journal of Parkinson’s Disease, February 2021, IOS Press

    Prof. Cristoforo Comi

  95. Paraneoplastic neuromyelitis optica spectrum disorders: a case series

    Article • Neurological Sciences, January 2021, Springer Science + Business Media

    Prof. Cristoforo Comi

  96. Expanding the genetic spectrum of primary familial brain calcification due to SLC2OA2 mutations: a case series

    Article • Neurogenetics, January 2021, Springer Science + Business Media

    Prof. Cristoforo Comi

  97. The Yin-Yang of osteopontin in nervous system diseases: damage versus repair

    Article • Neural Regeneration Research, January 2021, Medknow

    Prof. Cristoforo Comi

  98. Potential protective role of ACE-inhibitors and AT1 receptor blockers against levodopa-induced dyskinesias: a retrospective case-control study

    Article • Neural Regeneration Research, January 2021, Medknow

    Prof. Cristoforo Comi

  99. Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients

    Article • Scientific Reports, November 2020, Springer Science + Business Media

    Prof. Cristoforo Comi

  100. Intrathecal kappa free light chains as markers for multiple sclerosis

    Article • Scientific Reports, November 2020, Springer Science + Business Media

    Prof. Cristoforo Comi

  101. Genetic parkinsonisms and cancer: a systematic review and meta-analysis

    Article • Reviews in the Neurosciences, November 2020, De Gruyter

    Prof. Cristoforo Comi

  102. Change over time of COVID-19 hospital presentation in Northern Italy

    Article • European Journal of Internal Medicine, November 2020, Elsevier

    Prof. Cristoforo Comi

  103. Relationship between circulating CD4+ T lymphocytes and cognitive impairment in patients with Parkinson’s disease

    Article • Brain Behavior and Immunity, October 2020, Elsevier

    Prof. Cristoforo Comi

  104. Kinematic but not clinical measures predict falls in Parkinson-related orthostatic hypotension

    Article • Deutsche Zeitschrift für Nervenheilkunde, September 2020, Springer Science + Business Media

    Prof. Cristoforo Comi

  105. CD4 + T‐Cell Transcription Factors in Idiopathic REM Sleep Behavior Disorder and Parkinson’s Disease

    Article • Movement Disorders, July 2020, Wiley

    Prof. Cristoforo Comi

  106. Cortical visuomotor interactions in Freezing of Gait: A TMS approach

    Article • Neurophysiologie Clinique, July 2020, Elsevier

    Prof. Cristoforo Comi

  107. Correction to: The TANDEM investigation: efficacy and tolerability of levodopa-carbidopa intestinal gel in (LCIG) advanced Parkinson’s disease patients

    Article • Acta Neurovegetativa, June 2020, Springer Science + Business Media

    Prof. Cristoforo Comi, Dr. Nicola Tambasco

  108. The TANDEM investigation: efficacy and tolerability of levodopa-carbidopa intestinal gel in (LCIG) advanced Parkinson’s disease patients

    Article • Acta Neurovegetativa, March 2020, Springer Science + Business Media

    Prof. Cristoforo Comi, Dr. Nicola Tambasco

  109. Meet Our Editorial Board Member

    Article • Current Pharmaceutical Biotechnology, February 2020, Bentham Science Publishers

    Prof. Cristoforo Comi

  110. Nerve conduction, circulating osteopontin and taxane-induced neuropathy in breast cancer patients

    Article • Neurophysiologie Clinique, February 2020, Elsevier

    Prof. Cristoforo Comi

  111. Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk

    Article • Cell, January 2020, Elsevier

    Dr Jacob L McCauley, Prof. Cristoforo Comi

  112. Vogt-Koyanagi-Harada Syndrome: A Case of Bilateral Steroid-Responsive Loss of Vision

    Article • December 2019, sPage.direcT

    Prof. Cristoforo Comi

  113. Editorial: Peripheral Immunity in Parkinson's Disease: Emerging Role and Novel Target for Therapeutics

    Article • Frontiers in Neurology, October 2019, Frontiers

    Prof. Cristoforo Comi

  114. Meet Our Editorial Board Member

    Article • Current Pharmaceutical Biotechnology, September 2019, Bentham Science Publishers

    Prof. Cristoforo Comi

  115. Meet Our Editorial Board Member

    Article • CNS & Neurological Disorders - Drug Targets, September 2019, Bentham Science Publishers

    Prof. Cristoforo Comi

  116. TAM Receptor Pathways at the Crossroads of Neuroinflammation and Neurodegeneration

    Article • Disease Markers, September 2019, Hindawi Publishing Corporation

    Prof. Cristoforo Comi

  117. The vermiform appendix in Parkinson's disease: At the crossroad of peripheral immunity, the nervous system and the intestinal microbiome

    Article • Autoimmunity Reviews, September 2019, Elsevier

    Prof. Cristoforo Comi

  118. Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk

    Article • Cell, June 2019, Elsevier

    Prof. Cristoforo Comi

  119. FRI0258 ANTI-RO/SSA POSITIVITY, ANTI-AQUAPORIN4 ANTIBODIES AND CENTRAL NERVOUS SYSTEM INVOLVEMENT: A RETROSPECTIVE STUDY ON A CONTROVERSIAL CORRELATION

    Article • June 2019, BMJ

    Prof. Cristoforo Comi

  120. Probiotics May Have Beneficial Effects in Parkinson's Disease: In vitro Evidence

    Article • Frontiers in Immunology, May 2019, Frontiers

    Prof. Cristoforo Comi

  121. Kappa free light chains could predict early disease course in multiple sclerosis

    Article • Multiple Sclerosis and Related Disorders, May 2019, Elsevier

    Prof. Cristoforo Comi

  122. Meet Our Editorial Board Member

    Article • Current Pharmaceutical Biotechnology, April 2019, Bentham Science Publishers

    Prof. Cristoforo Comi

  123. K Index is a Reliable Marker of Intrathecal Synthesis, and an Alternative to IgG Index in Multiple Sclerosis Diagnostic Work-Up

    Article • Journal of Clinical Medicine, April 2019, MDPI AG

    Prof. Cristoforo Comi

  124. Untangling Extracellular Proteasome-Osteopontin Circuit Dynamics in Multiple Sclerosis

    Article • Cells, March 2019, MDPI AG

    Prof. Cristoforo Comi

  125. Holmes tremor caused by a natalizumab-related progressive multifocal leukoencephalopathy: a case report and brief review of the literature

    Article • Neurological Sciences, March 2019, Springer Science + Business Media

    Prof. Cristoforo Comi

  126. Ultrasonography Monitoring of Optic Nerve Sheath Diameter and Retinal Vessels in Patients with Cerebral Hemorrhage

    Article • Journal of Neuroimaging, February 2019, Wiley

    Prof. Cristoforo Comi

  127. Post-lumbar puncture headache: an adverse effect in multiple sclerosis work-up

    Article • Neurological Sciences, January 2019, Springer Science + Business Media

    Prof. Cristoforo Comi

  128. Exploiting PLGA-Based Biocompatible Nanoparticles for Next-Generation Tolerogenic Vaccines against Autoimmune Disease

    Article • International Journal of Molecular Sciences, January 2019, MDPI AG

    Prof. Cristoforo Comi

  129. Beta2-Adrenoceptor Agonists in Parkinson’s Disease and Other Synucleinopathies

    Article • Journal of Neuroimmune Pharmacology, January 2019, Springer Science + Business Media

    Prof. Cristoforo Comi

  130. Antiphospholipid Syndrome and the Neurologist: From Pathogenesis to Therapy

    Article • Frontiers in Neurology, November 2018, Frontiers

    Prof. Cristoforo Comi

  131. The Italian multiple sclerosis register

    Article • Neurological Sciences, November 2018, Springer Science + Business Media

    Prof. Cristoforo Comi, Prof Massimiliano Valeriani

  132. LncRNAs expression profile in peripheral blood mononuclear cells from multiple sclerosis patients

    Article • Journal of Neuroimmunology, November 2018, Elsevier

    Prof. Cristoforo Comi

  133. Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk

    Article • Cell, November 2018, Elsevier

    Prof. Cristoforo Comi, Dr Jacob L McCauley

  134. CSF biomarkers of neurodegeration in early multiple sclerosis course

    Article • September 2018, Morressier

    Prof. Cristoforo Comi

  135. Parkinson’s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients

    Article • Journal of Neuroinflammation, July 2018, Springer Science + Business Media

    Prof. Cristoforo Comi

  136. LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study

    Article • The Lancet Neurology, July 2018, Elsevier

    Professor Piero Parchi, Alessio Di Fonzo, Prof. Cristoforo Comi, Dr ir Wilfred van IJcken

  137. Chronic obstructive pulmonary disease may complicate Alzheimer’s disease: a comorbidity problem

    Article • Neurological Sciences, June 2018, Springer Science + Business Media

    Prof. Cristoforo Comi

  138. MOG-antibody demyelinating diseases: a case of post-partum severe rhombencephalitis and transverse myelitis

    Article • Multiple Sclerosis and Related Disorders, April 2018, Elsevier

    Prof. Cristoforo Comi

  139. The Length of SNCA Rep1 Microsatellite May Influence Cognitive Evolution in Parkinson’s Disease

    Article • Frontiers in Neurology, March 2018, Frontiers

    Prof. Cristoforo Comi, Alessio Di Fonzo

  140. Real life evaluation of safinamide effectiveness in Parkinson’s disease

    Article • Neurological Sciences, February 2018, Springer Science + Business Media

    Prof. Cristoforo Comi, Alessio Di Fonzo

  141. Long non coding RNA expression profile in Peripheral Blood Mononuclear Cells from Multiple Sclerosis patients: potential biomarkers of disease susceptibility and progression

    Article • October 2017, Morressier

    Prof. Cristoforo Comi

  142. O158 Excessive inhibitory visuomotor connections in parkinson’s disease with freezing of gait

    Article • Clinical Neurophysiology, September 2017, Elsevier

    Prof. Cristoforo Comi

  143. A patient with autoimmune limb-girdle myasthenia, and a brief review of this treatable condition.

    Article • Clinical Neurology and Neurosurgery, July 2017, Elsevier

    Prof. Cristoforo Comi

  144. Peripheral neuropathy as marker of severe Parkinson's disease phenotype

    Article • Movement Disorders, May 2017, Wiley

    Maurizio Zibetti, Prof. Cristoforo Comi

  145. Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up

    Article • Parkinsonism & Related Disorders, May 2017, Elsevier

    Prof. Cristoforo Comi, Dr. Nicola Tambasco

  146. The measuring of substantia nigra hyperechogenicity in an Italian cohort of Parkinson disease patients: a case/control study (NOBIS Study)

    Article • Acta Neurovegetativa, April 2017, Springer Science + Business Media

    Prof. Cristoforo Comi

  147. Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis

    Article • Frontiers in Immunology, March 2017, Frontiers

    Prof. Cristoforo Comi

  148. Extracellular proteasome-osteopontin circuit regulates cell migration with implications in multiple sclerosis

    Article • Scientific Reports, March 2017, Springer Science + Business Media

    Prof. Cristoforo Comi

  149. Prevalence and burden of dysautonomia in advanced Parkinson's disease

    Article • Movement Disorders, March 2017, Wiley

    Prof. Cristoforo Comi, Carlo Alberto Artusi

  150. Polymorphisms of Dopamine Receptor Genes and Risk of L-Dopa–Induced Dyskinesia in Parkinson’s Disease

    Article • International Journal of Molecular Sciences, January 2017, MDPI AG

    Prof. Cristoforo Comi

  151. Combined use of Kappa Free Light Chain Index and Isoelectrofocusing of Cerebro-Spinal Fluid in Diagnosing Multiple Sclerosis: Performances and Costs

    Article • Clinical Laboratory, January 2017, Clinical Laboratory Publications

    Prof. Cristoforo Comi

  152. Insights into the protective role of immunity in neurodegenerative disease

    Article • Neural Regeneration Research, January 2017, Medknow

    Prof. Cristoforo Comi

  153. Longitudinal Assessment of Transorbital Sonography, Visual Acuity, and Biomarkers for Inflammation and Axonal Injury in Optic Neuritis

    Article • Disease Markers, January 2017, Hindawi Publishing Corporation

    Prof. Cristoforo Comi, Dr Raffaele Nardone, Piergiorgio Lochner, Francesco Brigo, Dr Antonio Siniscalchi

  154. Transorbital Sonography and Visual Outcome for the Diagnosis and Monitoring of Optic Neuritis

    Article • Journal of Neuroimaging, November 2016, Wiley

    Prof. Cristoforo Comi

  155. Growth Arrest Specific 6 Concentration is Increased in the Cerebrospinal Fluid of Patients with Alzheimer’s Disease

    Article • Journal of Alzheimer’s Disease, November 2016, IOS Press

    Prof. Cristoforo Comi

  156. Dopaminergic Receptors on CD4+ T Naive and Memory Lymphocytes Correlate with Motor Impairment in Patients with Parkinson’s Disease

    Article • Scientific Reports, September 2016, Springer Science + Business Media

    Prof. Cristoforo Comi

  157. Polymorphisms of dopamine receptor genes and risk of visual hallucinations in Parkinson’s patients

    Article • European Journal of Clinical Pharmacology, August 2016, Springer Science + Business Media

    Prof. Cristoforo Comi

  158. Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia

    Article • British Journal of Haematology, July 2016, Wiley

    Prof. Cristoforo Comi

  159. D NAJC 6 Mutations Associated With Early-Onset Parkinson's Disease

    Article • Annals of Neurology, January 2016, Wiley

    Prof. Cristoforo Comi

  160. Polymorphisms of dopamine receptor genes are associated to increased risk of visual hallucinations in Italian Parkinson's disease patients

    Article • Parkinsonism & Related Disorders, January 2016, Elsevier

    Prof. Cristoforo Comi

  161. Osteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases

    Article • Journal of Immunology Research, January 2016, Hindawi Publishing Corporation

    Prof. Cristoforo Comi

  162. Thrombin Cleavage of Osteopontin Modulates Its Activities in Human CellsIn Vitroand Mouse Experimental Autoimmune EncephalomyelitisIn Vivo

    Article • Journal of Immunology Research, January 2016, Hindawi Publishing Corporation

    Prof. Cristoforo Comi

  163. Impaired visual inhibition in migraine with aura

    Article • Clinical Neurophysiology, October 2015, Elsevier

    Prof. Cristoforo Comi

  164. MRI imaging and clinical features of sciatic nerve injection injury

    Article • International Journal of Neuroscience, May 2015, Taylor & Francis

    Prof. Cristoforo Comi

  165. Peripheral nervous system involvement in Parkinson's disease: Evidence and controversies

    Article • Parkinsonism & Related Disorders, December 2014, Elsevier

    Prof. Cristoforo Comi

  166. Variations of the perforin gene in patients with chronic inflammatory demyelinating polyradiculoneuropathy

    Article • Genes & Immunity, October 2014, Springer Science + Business Media

    Prof. Cristoforo Comi

  167. Predicting Cognitive Decline in Parkinson’s Disease: Can We Ask the Genes?

    Article • Frontiers in Neurology, October 2014, Frontiers

    Prof. Cristoforo Comi

  168. Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis

    Article • Vaccine, September 2014, Elsevier

    Prof. Cristoforo Comi

  169. Intensive Rehabilitation Treatment in Early Parkinson’s Disease

    Article • Neurorehabilitation and Neural Repair, July 2014, SAGE Publications

    Prof. Cristoforo Comi

  170. Transorbital Sonography in Acute Optic Neuritis: A Case-Control Study

    Article • American Journal of Neuroradiology, July 2014, American Society of Neuroradiology (ASNR)

    Prof. Cristoforo Comi

  171. Joint Congress of European Neurology 31 May–3 June 2014 Istanbul, Turkey

    Article • Deutsche Zeitschrift für Nervenheilkunde, May 2014, Springer Science + Business Media

    Prof. Cristoforo Comi

  172. Advances in Neuroimmunology: From Bench to Bedside

    Article • Autoimmune Diseases, January 2014, Hindawi Publishing Corporation

    Prof. Cristoforo Comi

  173. Current Understanding on the Role of Standard and Immunoproteasomes in Inflammatory/Immunological Pathways of Multiple Sclerosis

    Article • Autoimmune Diseases, January 2014, Hindawi Publishing Corporation

    Prof. Cristoforo Comi

  174. Prevalence and features of peripheral neuropathy in Parkinson's disease patients under different therapeutic regimens

    Article • Parkinsonism & Related Disorders, January 2014, Elsevier

    Prof. Cristoforo Comi

  175. Revisiting the Molecular Mechanism of Neurological Manifestations in Antiphospholipid Syndrome: Beyond Vascular Damage

    Article • Journal of Immunology Research, January 2014, Hindawi Publishing Corporation

    Prof. Cristoforo Comi

  176. Treatment of Chronic Inflammatory Demyelinating Polyneuropathy: From Molecular Bases to Practical Considerations

    Article • Autoimmune Diseases, January 2014, Hindawi Publishing Corporation

    Prof. Cristoforo Comi

  177. Evidence of Pre-Synaptic Dopaminergic Deficit in a Patient with a Novel Progranulin Mutation Presenting with Atypical Parkinsonism†

    Article • Journal of Alzheimer’s Disease, December 2013, IOS Press

    Prof. Cristoforo Comi

  178. Intensive Rehabilitation Increases BDNF Serum Levels in Parkinsonian Patients

    Article • Neurorehabilitation and Neural Repair, November 2013, SAGE Publications

    Prof. Cristoforo Comi

  179. Variations of the UNC13D Gene in Patients with Autoimmune Lymphoproliferative Syndrome

    Article • PLOS One, July 2013, PLOS

    Prof. Cristoforo Comi

  180. Defining the Epsilon-Sarcoglycan (SGCE) Gene Phenotypic Signature in Myoclonus-Dystonia: A Reappraisal of Genetic Testing Criteria

    Article • Movement Disorders, May 2013, Wiley

    Prof. Cristoforo Comi

  181. Robotic gait training is not superior to conventional treadmill training in Parkinson's Disease: A single-blind randomized controlled trial

    Article • Gait & Posture, April 2013, Elsevier

    Prof. Cristoforo Comi

  182. Discovery and verification of panels of T-lymphocyte proteins as biomarkers of Parkinson's disease

    Article • Scientific Reports, December 2012, Springer Science + Business Media

    Prof. Cristoforo Comi

  183. The role of T cell apoptosis in nervous system autoimmunity

    Article • Autoimmunity Reviews, December 2012, Elsevier

    Prof. Cristoforo Comi

  184. Dopaminergic therapies modulate the T-CELL proteome of patients with Parkinson's disease

    Article • IUBMB Life, July 2012, Wiley

    Prof. Cristoforo Comi

  185. Rehabilitation improves dyskinesias in Parkinsonian patients: A pilot study comparing two different rehabilitative treatments

    Article • NeuroRehabilitation, June 2012, IOS Press

    Prof. Cristoforo Comi

  186. Robotic Gait Training Is not Superior to Conventional Treadmill Training in Parkinson Disease

    Article • Neurorehabilitation and Neural Repair, May 2012, SAGE Publications

    Prof. Cristoforo Comi

  187. The -346T polymorphism of the SH2D1A gene is a risk factor for development of autoimmunity/lymphoproliferation in males with defective Fas function

    Article • Human Immunology, May 2012, Elsevier

    Prof. Cristoforo Comi

  188. The Impact of Osteopontin Gene Variations on Multiple Sclerosis Development and Progression

    Article • Clinical and Developmental Immunology, January 2012, Hindawi Publishing Corporation

    Prof. Cristoforo Comi

  189. Cerebrospinal Fluid Biomarkers in Progranulin Mutations Carriers

    Article • Journal of Alzheimer’s Disease, December 2011, IOS Press

    Prof. Cristoforo Comi

  190. Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis

    Article • Neuroscience Letters, October 2011, Elsevier

    Prof. Cristoforo Comi

  191. Effectiveness of Intensive Inpatient Rehabilitation Treatment on Disease Progression in Parkinsonian Patients

    Article • Neurorehabilitation and Neural Repair, August 2011, SAGE Publications

    Prof. Cristoforo Comi

  192. The Role of Osteopontin in Neurodegenerative Diseases

    Article • Journal of Alzheimer’s Disease, July 2011, IOS Press

    Prof. Cristoforo Comi

  193. Fas-mediated T-cell apoptosis in chronic inflammatory demyelinating polyneuropathy

    Article • Journal of the Peripheral Nervous System, June 2011, Wiley

    Prof. Cristoforo Comi

  194. GSK3β genetic variability in patients with Multiple Sclerosis

    Article • Neuroscience Letters, June 2011, Elsevier

    Prof. Cristoforo Comi

  195. Progressive multifocal leucoencephalopathy after autologous bone marrow transplantation: a treatment option

    Article • BMJ Case Reports, April 2011, BMJ

    Prof. Cristoforo Comi

  196. Complex pattern of convulsive syncope in glossopharyngeal neuralgia: Video/EEG report and short review

    Article • Epilepsy & Behavior, February 2011, Elsevier

    Prof. Cristoforo Comi

  197. Levodopa‐induced belly dancer's dyskinesias in Parkinson's disease: Report of one case

    Article • Movement Disorders, August 2010, Wiley

    Prof. Cristoforo Comi

  198. Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature

    Article • Journal of Neurology Neurosurgery & Psychiatry, July 2010, BMJ

    Prof. Cristoforo Comi

  199. Signals of Apoptotic Pathways in Several Types of Meningioma

    Article • Pathology & Oncology Research, June 2010, Springer Science + Business Media

    Prof. Cristoforo Comi

  200. Progranulin gene variability increases the risk for primary progressive multiple sclerosis in males

    Article • Genes & Immunity, May 2010, Springer Science + Business Media

    Prof. Cristoforo Comi

  201. Osteopontin is Increased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease and Its Levels Correlate with Cognitive Decline

    Article • Journal of Alzheimer’s Disease, March 2010, IOS Press

    Prof. Cristoforo Comi

  202. Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease

    Article • Journal of the Neurological Sciences, December 2009, Elsevier

    Prof. Cristoforo Comi

  203. A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy

    Article • European Journal of Neurology, October 2009, Wiley

    Prof. Cristoforo Comi

  204. FP17-TU-06 Th17, an effector T lymphocyte subset associated with multiple sclerosis (MS) relapses: antigen specificity, cytokine production, and sensitivity to interferon (IFN)-β

    Article • Journal of the Neurological Sciences, October 2009, Elsevier

    Prof. Cristoforo Comi

  205. Defective Fas-mediated T-cell apoptosis predicts acute onset CIDP

    Article • Journal of the Peripheral Nervous System, June 2009, Wiley

    Prof. Cristoforo Comi

  206. Complex movement disorders in primary antiphospholipid syndrome: A case report

    Article • Journal of the Neurological Sciences, June 2009, Elsevier

    Prof. Cristoforo Comi

  207. Spontaneous Intracranial Hypotension Presenting as a Reversible Dorsal Midbrain Syndrome

    Article • Journal of Neuro-Ophthalmology, December 2008, Wolters Kluwer Health

    Prof. Cristoforo Comi

  208. Variations of the perforin gene in patients with multiple sclerosis

    Article • Genes & Immunity, May 2008, Springer Science + Business Media

    Prof. Cristoforo Comi

  209. Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to Multiple Sclerosis

    Article • Journal of the Neurological Sciences, April 2008, Elsevier

    Prof. Cristoforo Comi

  210. MDC/CCL22 intrathecal levels in patients with multiple sclerosis

    Article • Multiple Sclerosis Journal, January 2008, SAGE Publications

    Prof. Cristoforo Comi

  211. Candidate gene analysis of SPARCL1 gene in patients with multiple sclerosis

    Article • Neuroscience Letters, October 2007, Elsevier

    Prof. Cristoforo Comi

  212. ICOS gene haplotypes correlate with IL10 secretion and multiple sclerosis evolution

    Article • Journal of Neuroimmunology, May 2007, Elsevier

    Prof. Cristoforo Comi

  213. CXCL10 haplotypes and multiple sclerosis: association and correlation with clinical course

    Article • European Journal of Neurology, February 2007, Wiley

    Prof. Cristoforo Comi

  214. ICOS cooperates with CD28, IL-2, and IFN-γ and modulates activation of human naïve CD4+ T cells

    Article • European Journal of Immunology, October 2006, Wiley

    Prof. Cristoforo Comi

  215. Fas-mediated T-cell apoptosis is impaired in patients with chronic inflammatory demyelinating polyneuropathy

    Article • Journal of the Peripheral Nervous System, March 2006, Wiley

    Prof. Cristoforo Comi

  216. P-selectin glycoprotein ligand-1 variable number of tandem repeats (VNTR) polymorphism in patients with multiple sclerosis

    Article • Neuroscience Letters, November 2005, Elsevier

    Prof. Cristoforo Comi

  217. E-selectin A561C and G98T polymorphisms influence susceptibility and course of multiple sclerosis

    Article • Journal of Neuroimmunology, August 2005, Elsevier

    Prof. Cristoforo Comi

  218. Osteopontin gene haplotypes correlate with multiple sclerosis development and progression

    Article • Journal of Neuroimmunology, June 2005, Elsevier

    Prof. Cristoforo Comi

  219. Cutaneous silent period in human immunodeficiency virus-related peripheral neuropathy

    Article • Journal of the Peripheral Nervous System, December 2004, Wiley

    Prof. Cristoforo Comi

  220. Abnormal response to glutamate of T lymphocytes from multiple sclerosis patients

    Article • Neuroscience Letters, April 2003, Elsevier

    Prof. Cristoforo Comi

  221. Diagnosis of psychogenic paralysis: The role of motor evoked potentials

    Article • Deutsche Zeitschrift für Nervenheilkunde, October 2001, Springer Science + Business Media

    Prof. Cristoforo Comi

  222. Anticonvulsvant Drugs and Cognitive Functions in Elderly Patients with Epilepsy

    Article • June 2001, Taylor & Francis

    Prof. Cristoforo Comi

  223. Anticonvulsant Drugs and Cognitive Functions in Elderly Patients with Epilepsy

    Article • June 2001, Taylor & Francis

    Prof. Cristoforo Comi

  224. Defective T cell Fas function in patients with multiple sclerosis

    Article • Neurology, October 2000, Wolters Kluwer Health

    Prof. Cristoforo Comi

  225. Deficiency of the Fas apoptosis pathway without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer

    Article • Blood, May 2000, American Society of Hematology

    Prof. Cristoforo Comi